XSHG
600381
Market cap352mUSD
Oct 09, Last price
4.13CNY
1D
0.24%
1Q
-5.92%
Jan 2017
-73.22%
IPO
-75.06%
Name
Qinghai Spring Medicinl Rsrcs Tech CoLTD
Chart & performance
P/E
—
P/S
6.88
EPS
—
Div yield, %
—
Shrs. gr., 5y
-2.06%
Rev. gr., 5y
22.54%
Revenues
343m
+27.07%
Net income
0
P
CFO
-26m
L
Dividend
May 21, 20030.052371 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Qinghai Spring Medicinal Resources Technology Co., Ltd. specializes in the research, development, and commercialization of cordyceps products. Its operations further extend to the distribution of beverages and aquatic items, providing advertising solutions, and conducting foreign investment activities. The company was established in 2003 and is headquartered in Xining, China.
Key people
Lin Wang
Chief Financial Officer · since 2018
Xiaodong Li
General Manager, Director
Lin Wang
Chief Financial Officer, Deputy General Manager · since 2011
Zhi Liao
Director · since 2013
Xuefeng Zhang
Chairman of the Board, General Manager · since 2017
Independent Director · since 2013
Ying Qian
Independent Director · since 2013
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||